⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
Pulmonary Edema (2026-2031) - Rising Prevalence of Cardiovascular Diseases Drives Market Growth
globenewswire.com
ABBV
AZN
BSX
BMY
EL
LLY
JNJ
MRK
NVS
PFE
SNY
VTRS
Upper Respiratory Tract Infection Treatment (2026-2031) - Rising Prevalence of Respiratory Infections Drives Market Growth
globenewswire.com
ABT
ABBV
ALC
AZN
BMY
CI
DDS
JNJ
MRK
NVS
PFE
SNY
TEVA
VTRS
Global Cardiometabolic Drugs 2026-2031 - Rising Cardiometabolic Disease Prevalence Drives Market Growth
globenewswire.com
LLY
NVO
AZN
BMY
PFE
MRK
AMGN
ABBV
GILD
Benchling Brings Chemistry and Biology Together on One R&D Platform, Adds Chemistry Reactions and Predictive Models
prnewswire.com
MRK
MRNA
SNY
Ingenia Therapeutics Nominated for Both the Prix Galien USA and the Inaugural Prix Galien Korea for Best Startup
businesswire.com
MRK
Wyoming Selects OneNexus to Operate Nation's First State-Backed Oil and Gas Bonding Pool
prnewswire.com
TRV
MRK
Active Pharmaceutical Ingredients (API) Market Report 2026-2036 Just Released — Analyses Synthetic, Biotech, Traditional and Highly Potent APIs
globenewswire.com
MRK
PFE
NVS
EndoCyclic Therapeutics Nominated for 2026 Prix Galien USA Award
prnewswire.com
MRK
Merck and Moderna Announce Phase 3 INTerpath-001 Trial of Intismeran Autogene Plus KEYTRUDA ® Met Endpoints of Recurrence-Free Survival (RFS) and Distant Metastasis-Free Survival (DMFS) in Patients With Completely Resected Stage IIB-IV Melanoma
businesswire.com
MRNA
MRK
Global Atipamezole Market to Reach $194.27 Million by 2031 as Veterinary Sedation Reversal Demand Rises
globenewswire.com
ZTS
MRK